SpanishSpanish    SMSSend SMS
Yashica Pharmaceuticals
Yashica Pharmaceuticals
Yashica Pharmaceuticals

Yashica Pharmaceuticals

Yashica

Yashica PharmaceuticalsYashica Pharmaceuticals

Home » Finished Formulation » Erythromycin Stearate Tablets

Erythromycin Stearate Tablets

Capitalizing on our adept professionals, we bring forth accurately composed Yashimycin Tablet 250 mg BP that is used to cure bacterial infections and maintains the immunity system of the human body. It is composed of the stearate salt of Erythromycin.Erythromycin is known as a macrolide antibiotic. It works by stopping the growth of bacteria and eradicate the organism from the body.


Remedy:
  • Indicated for the treatment of patients with mild to moderate infections
Composition:
  • Each film coated tablet contains: erythromycin stearate BP, equivalent to erythromycin 250 mg, excipients q.s.
  • Colour: Erythrosine
Dosage:
  • Adults: The dosage is 250 mg every 6 hours; or 500 mg every 12 hours. Dosage may be increased up to 4 g per day according to the severity of the infection. However, twice-a-day dosing is not recommended when doses larger than 1 g daily are administered.
  • Children: Age, weight, and severity of the infection are important factors in determining the proper dosage. The usual dosage is 30 to 50 mg/kg/day, in equally divided doses. For more severe infections this dosage may be doubled but should not exceed 4 g per day.
Rout administration:
  • Oral
Contraindications:
  • Erythromycin is contraindicated in patients taking terfenadine, astemizole, pimozide or cisapride.
Warnings and Precautions:
  • Before taking erythromycin, tell your doctor or pharmacist if you are allergic to it; or to other macrolide antibiotics (e.g., azithromycin, clarithromycin); or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems.
Adverse Effects:
  • Occasional side effects such as nausea, abdominal discomfort, vomiting and diarrhoea may be experienced. Reversible hearing loss associated with doses of erythromycin usually greater than 4g per day has been reported. As with other broad spectrum antibiotics, pseudomembranous colitis has been reported rarely with erythromycin.
  • Allergic reactions are rare and mild, although anaphylaxis has occurred. Skin reactions ranging from mild eruptions to erythema multiforme, Stevens - Johnson syndrome and toxic epidermal necrolysis have rarely been reported.
  • There are no reports implicating erythromycin products with abnormal tooth development, and only rare reports of damage to the blood, kidneys or central nervous system.
  • Cardiac arrhythmias have been very rarely reported in patients receiving erythromycin therapy. There have been isolated reports of chest pain, dizziness and palpitations; however, a cause and effect relationship has not been established. Symptoms of hepatitis, hepatic dysfunction and/or abnormal liver function test results may occur. The rare possibility of super infection caused by overgrowth of non-susceptible bacteria or fungi should be considered during prolonged or repeated therapy, especially when other antibacterial agents are simultaneously employed.
Overdosage:
  • In case of overdosage, erythromycin should be discontinued. Overdosage should be handled with the prompt elimination of unabsorbed drug and all other appropriate measures should be instituted. Erythromycin is not removed by peritoneal dialysis or hemodialysis.
Indications:
  • Erythromycin stearate tablets are indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below:
  • Acute otitis media (AOM), pharyngitis and tonsillitis, respiratory infections, campylobacter infections, chancroid chlamydial infections, diphtheria, granuloma inguinale tract infections, skin and skin structure infections, acne, amebiasis, anthrax, bartonella (Donovanosis), legionnaires’ disease, lyme disease, nongonococcal urethritis, pelvic inflammatory disease (PID), pertussis, syphilis, preoperative intestinal antisepsis, prevention of bacterial endocarditis, prevention of rheumatic fever recurrence, prevention of perinatal group B streptococcal disease.
Presentation:
  • 10 x10 Tablets in Blister pack
Storage:
  • Store below 25℃ in cool and dry place, in original container

Yes! I am Interested

Erythromycin Stearate Tablet 500mg BP

Capitalizing on our adept professionals, we bring forth accurately composed Yashimycin Tablet 500mg BP that is used to cure bacterial infections & maintains the immunity system of the human body. It is composed of the stearate salt of Erythromycin.Erythromycin is known as a macrolide antibiotic. It works by stopping the growth of bacteria and eradicate the organism from the body.


Remedy:
  • Indicated for the treatment of patients with mild to moderate infections
Composition:
  • Each film coated tablet contains: erythromycin stearate BP, equivalent to erythromycin 500 mg, excipients q.s.
  • Colour: Erythrosine
Dosage:
  • Adults: The dosage is 250 mg every 6 hours; or 500 mg every 12 hours. Dosage may be increased up to 4 g per day according to the severity of the infection. However, twice-a-day dosing is not recommended when doses larger than 1 g daily are administered.
  • Children: Age, weight, and severity of the infection are important factors in determining the proper dosage. The usual dosage is 30 to 50 mg/kg/day, in equally divided doses. For more severe infections this dosage may be doubled but should not exceed 4 g per day.
Rout administration:
  • Oral
Contraindications:
  • Erythromycin is contraindicated in patients taking terfenadine, astemizole, pimozide or cisapride.
Warnings and Precautions:
  • Before taking erythromycin, tell your doctor or pharmacist if you are allergic to it; or to other macrolide antibiotics (e.g., azithromycin, clarithromycin); or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems.
Adverse Effects:
  • Occasional side effects such as nausea, abdominal discomfort, vomiting and diarrhoea may be experienced. Reversible hearing loss associated with doses of erythromycin usually greater than 4g per day has been reported.
  • As with other broad spectrum antibiotics, pseudomembranous colitis has been reported rarely with erythromycin.
  • Allergic reactions are rare and mild, although anaphylaxis has occurred. Skin reactions ranging from mild eruptions to erythema multiforme, Stevens - Johnson syndrome and toxic epidermal necrolysis have rarely been reported.
  • There are no reports implicating erythromycin products with abnormal tooth development, and only rare reports of damage to the blood, kidneys or central nervous system.
  • Cardiac arrhythmias have been very rarely reported in patients receiving erythromycin therapy. There have been isolated reports of chest pain, dizziness and palpitations; however, a cause and effect relationship has not been established. Symptoms of hepatitis, hepatic dysfunction and/or abnormal liver function test results may occur. The rare possibility of super infection caused by overgrowth of non-susceptible bacteria or fungi should be considered during prolonged or repeated therapy, especially when other antibacterial agents are simultaneously employed.
Overdosage:
  • In case of overdosage, erythromycin should be discontinued. Overdosage should be handled with the prompt elimination of unabsorbed drug and all other appropriate measures should be instituted. Erythromycin is not removed by peritoneal dialysis or hemodialysis.
Indications:
  • Erythromycin Stearate Tablets are indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below:
  • Acute Otitis Media (AOM), Pharyngitis and Tonsillitis, Respiratory Tract Infections, Skin and skin structure infections, Acne, Amebiasis, Anthrax, Bartonella infections, Campylobacter infections, Chancroid Chlamydial infections, Diphtheria, Granuloma Inguinale (Donovanosis), Legionnaires’ Disease, Lyme Disease, Nongonococcal Urethritis, Pelvic Inflammatory Disease (PID), Pertussis, Syphilis, Preoperative intestinal antisepsis, Prevention of bacterial endocarditis, Prevention of Rheumatic Fever recurrence, Prevention of perinatal Group B Streptococcal Disease, etc
Presentation:
  • 10 x10 Tablets in Blister pack
Storage:
  • Store below 25°C in cool and dry place, in original container

Yes! I am Interested

Our Product Range :     Active Pharmaceuticals Ingredients |Drug Intermediates | Finished Formulation

Home|About Us|Our Product Range|Media Gallery|Contact Us|Enquiry

Member INDIAMART© Yashica Pharmaceuticals Private Limited. All Rights Reserved (Terms of Use)
Developed and Managed by IndiaMART InterMESH Limited

Looking for Product Name ?

x

Send SMS Enquiry

*Please Enter Requirment

*Please Enter valid Mobile Number

*Please Enter Proper Name